James Siegler to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications James Siegler has written about Platelet Aggregation Inhibitors.
Connection Strength
1.056
-
Anticoagulation Versus Antiplatelets in Spontaneous Cervical Artery Dissection: A Systematic Review and Meta-Analysis. Stroke. 2024 Jul; 55(7):1776-1786.
Score: 0.211
-
Editors' Note: IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke. Neurology. 2024 Mar 12; 102(5):e209236.
Score: 0.206
-
Low dose intravenous cangrelor versus glycoprotein IIb/IIIa inhibitors in endovascular treatment of tandem lesions. J Stroke Cerebrovasc Dis. 2023 Dec; 32(12):107438.
Score: 0.202
-
Embolic infarct topology differs between atrial fibrillation subtypes and embolic stroke of undetermined source. J Stroke Cerebrovasc Dis. 2022 Nov; 31(11):106782.
Score: 0.187
-
Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients. J Stroke Cerebrovasc Dis. 2013 Oct; 22(7):1184-9.
Score: 0.097
-
Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial. J Stroke Cerebrovasc Dis. 2024 Sep; 33(9):107839.
Score: 0.053
-
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024 Apr; 55(4):908-918.
Score: 0.051
-
Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions. Stroke. 2023 10; 54(10):2522-2533.
Score: 0.050